Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Legrand

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Revue Medicale De Liege|March 13, 2010
[Implementation of reperfusion therapy in ST segment elevation myocardial infarction (STEMI). A policy statement from the Belgian Society of Cardiology and its working group of acute cardiology and interventional cardiology]M J Claeys, S Gevaert, A de Meester, et al.
Revue Medicale De Bruxelles|April 14, 2010
[Implementation of reperfusion therapy in ST segment elevation myocardial infarction (STEMI). A policy statement from the Belgian Society of Cardiology and its working group of acute cardiology and interventional cardiology]M J Claeys, S Gevaert, A de Meester, et al.
Seminars in Interventional Cardiology : SIIC|December 1, 1996
Clinical and angiographic outcome of elective stent implantation in small coronary vessels: an analysis of the BENESTENT trialD Keane, A J Azar, P de Jaegere, et al.
Journal of the American College of Cardiology|May 10, 2001
Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trialF Kiemeneij, P W Serruys, C Macaya, et al.
Acta Cardiologica|January 1, 1997
BWGIC guidelines for training and quality control in adult interventional cardiology. Belgian Working Group of Invasive CardiologyV Legrand, M Vrolix, B De Bruyne, et al.
The Journal of Frailty & Aging|November 25, 2016
Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task ForceB Vellas, R Fielding, S Bhasin, et al.
Circulation|October 20, 1998
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) studyM E Bertrand, V Legrand, J Boland, et al.
European Heart Journal|August 9, 2001
The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions; final results of the Magic 5L StudyD P Foley, M Pieper, W Wijns, et al.
Lancet (London, England)|September 5, 1998
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)P W Serruys, B van Hout, H Bonnier, et al.
Circulation|December 13, 1997
Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire TransluminaleJ M Lablanche, E P McFadden, N Meneveau, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Revue Medicale De Liege|March 13, 2010
[Implementation of reperfusion therapy in ST segment elevation myocardial infarction (STEMI). A policy statement from the Belgian Society of Cardiology and its working group of acute cardiology and interventional cardiology]M J Claeys, S Gevaert, A de Meester, et al.
Revue Medicale De Bruxelles|April 14, 2010
[Implementation of reperfusion therapy in ST segment elevation myocardial infarction (STEMI). A policy statement from the Belgian Society of Cardiology and its working group of acute cardiology and interventional cardiology]M J Claeys, S Gevaert, A de Meester, et al.
Seminars in Interventional Cardiology : SIIC|December 1, 1996
Clinical and angiographic outcome of elective stent implantation in small coronary vessels: an analysis of the BENESTENT trialD Keane, A J Azar, P de Jaegere, et al.
Journal of the American College of Cardiology|May 10, 2001
Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trialF Kiemeneij, P W Serruys, C Macaya, et al.
Acta Cardiologica|January 1, 1997
BWGIC guidelines for training and quality control in adult interventional cardiology. Belgian Working Group of Invasive CardiologyV Legrand, M Vrolix, B De Bruyne, et al.
The Journal of Frailty & Aging|November 25, 2016
Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task ForceB Vellas, R Fielding, S Bhasin, et al.
Circulation|October 20, 1998
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) studyM E Bertrand, V Legrand, J Boland, et al.
European Heart Journal|August 9, 2001
The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions; final results of the Magic 5L StudyD P Foley, M Pieper, W Wijns, et al.
Lancet (London, England)|September 5, 1998
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)P W Serruys, B van Hout, H Bonnier, et al.
Circulation|December 13, 1997
Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire TransluminaleJ M Lablanche, E P McFadden, N Meneveau, et al.
Pageof 15